See also this year's filing and all EDGAR filings for this company.
PDF Report 0000744218_2024_Celldex_Therapeutics_Inc.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000744218, Celldex Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 5,331,000 |
| 1 | LiabilitiesCurrent | 31,125,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 431,693,000 |
| 4 | AssetsNoncurrent | 2,684,000 |
| 5 | PropertyPlantAndEquipmentNet | 4,060,000 |
| 6 | Goodwill | 27,190,000 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 30,914,000 |
| 9 | ResearchAndDevelopmentExpense | 118,011,000 |
| 10 | remainder_Expenses | 12,500,000 |
| 11 | remainder_Revenues | 19,996,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 2,048,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 36,456,000 |
| 1 | Assets | 465,627,000 |
| 2 | Expenses | 161,425,000 |
| 3 | Revenues | 19,996,000 |
| 4 | StockholdersEquity | 429,171,000 |
| 5 | NetIncome | -141,429,000 |
| 6 | ComprehensiveNetIncome | -140,405,000 |
| 7 | BaseVar | 342,776,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.78 |
| 9 | EconomicCapitalRatio | 2.20 |
Edgar->Model Mapping
Feature Distribution
Change over Time
